A $20 million gift will support research at UC Berkeley and UCSF into dyslexia and similar neurodevelopmental language-processing disorders as part of the new UCSF-UC Berkeley Schwab Dyslexia and Cognitive Diversity Center. The joint program will draw on research in neuroscience, cognitive psychology, education and public health, among other disciplines. At UC Berkeley, it will be headquartered in Berkeley Way West, the building that houses the UC Berkeley Department of Psychology, School of Public Health, and Graduate School of Education.
Transfer student Novene Cusseaux, from Vallejo, California, plans to study genetics and plant biology. “With genetics, there are a lot of things that haven’t been discovered yet. I just want to find out something new that we didn’t know existed... Now it should be my time to show my kids that you can do it at any age. You need to practice what you preach.”
The U.S. Patent and Trademark Office (USPTO) has awarded a new patent to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of producing a genetically modified cell through the introduction of the Cas9 protein, or a nucleic acid encoding the Cas9 protein, as well as a single molecule DNA-targeting RNA. This patent (U.S. 10,351,878) covers the use of this method in a cell.
Scientists focused on anticipating and preventing the major impacts ofclimate change shouldn’t forget the effect on Earth’s microbes, says Britt Koskella, an evolutionary biologist and assistant professor of integrative biology at UC Berkeley. “Bacteria, viruses and other microorganisms support the existence of all higher lifeforms... but are rarely the focus of climate change research, education or policy.”
Jennifer Doudna, a professor of molecular and cell biology and chemistry at Berkeley, and UCSF's Jonathan Weissman are the key players in a new collaboration with GlaxoSmithKline to apply CRISPR techniques to the discovery of new drug targets, potentially leading to new therapies for genetic diseases.